Using Reconsolidation Blockade to Treat Trauma Related Disorders After Paris Attacks: an Effectiveness Study

PHASE3CompletedINTERVENTIONAL
Enrollment

364

Participants

Timeline

Start Date

May 27, 2016

Primary Completion Date

December 30, 2019

Study Completion Date

December 30, 2019

Conditions
Post-traumatic Stress Disorder
Interventions
DRUG

β-adrenergic blocker propranolol

BEHAVIORAL

Treatment as usual

Trial Locations (20)

59037

CHRU et CIC de LILLE, Lille

75010

Hôpital Maison Blanche Hauteville, Paris

75012

Hôpital Saint Antoine, Paris

75013

Groupe Hospitalier Pitié-Salpêtrière, Paris

75020

Hôpital Tenon, Paris

75674

Hôpital Sainte-Anne, Paris

76301

Centre Hospitalier du Rouvray, Sotteville-lès-Rouen

77100

Grand Hôpital EST FRANCILIEN - site de Meaux, Meaux

77600

Grand Hôpital EST FRANCILIEN - site de Marne-la-Vallée, Jossigny

86021

Centre Hospitalier Henri Laborit, Poitiers

92130

Hôpital Corentin Celton, Issy-les-Moulineaux

92380

Hôpital Raymond Poincaré, Garches

93000

EPS Ville Evrard - site de Saint Denis, Saint-Denis

94010

Hôpital Albert Chenevier, Créteil

Hôpital Henri Mondor, Créteil

94270

Hôpital Bicêtre, Le Kremlin-Bicêtre

94410

Hôpitaux de Saint Maurice, Saint-Maurice

97261

Centre Hospitalier Universitaire de Martinique, Fort-de-France

06001

Chu Pasteur, Nice

06009

Centre Hospitalier Sainte Marie, Nice

All Listed Sponsors
collaborator

MSD France

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02789982 - Using Reconsolidation Blockade to Treat Trauma Related Disorders After Paris Attacks: an Effectiveness Study | Biotech Hunter | Biotech Hunter